Embedding a pharmacist-led clinic in early breast cancer treatment pathways
With rising demand and increasing complexity in breast cancer treatment, a pharmacist-led clinic in London is supporting service capacity while...
University of Nottingham awarded £1m to tackle pharmaceutical pollution in waterways
The PhRESHWater project will take place in Scotland, where antibiotics, anti-inflammatories and antidepressants have been previously detected in waterways....
HIV report highlights ‘stark contrast in access to PrEP among different ethnicities
The UK Health Security Agency has reported that PrEP uptake remains lowest in black African heterosexual women and men, at...
Regulator appoints council members for 2026 and 2027
The newly appointed members to the governing council comprise a range of backgrounds, which include pharmacists and pharmacy technicians....
Integrated care boards leave an uncertain future for the prescribing pathfinder programme
An investigation by The Pharmaceutical Journal has revealed geographic variation in the ongoing provision of the prescribing pathfinder programme, highlighting...
New stomach cancer treatment recommended by NICE after ‘light-touch’ assessment
Durvalumab, in combination with fluorouracil, leucovorin, oxaliplatin and docetaxel chemotherapy, blocks PD-L1 protein and allows the immune system to identify...